Teladoc's Earnings Miss as Revenue Falls
Teladoc Health (TDOC -1.70%), a leader in telehealth services, released its fourth-quarter earnings on Feb. 26. The company reported revenue of $640.5 million, just above the $639 million that analysts had expected, but 3% lower than the same quarter last year.
Teladoc shares tumble on wider-than-expected loss, disappointing revenue guidance
Teladoc Health shares fell in extended trading on Wednesday after the company issued weak guidance and reported a bigger loss than expected. Revenue at the telehealth company decreased 3% in the fourth quarter to $640.5 million.
What Analyst Projections for Key Metrics Reveal About Teladoc (TDOC) Q4 Earnings
Evaluate the expected performance of Teladoc (TDOC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Teladoc Health: Needs A Growth Catalyst
Teladoc Health is a beaten-down stock with stagnant revenue, priced attractively relative to its sector. Momentum for this stock has been building up as value investors anticipate a reversal. This momentum came after the company announced an AI product that will help physicians monitor their patients' movements remotely. In this article, I lay out my take on the stock, why I think conservative investors might have to wait for the growth catalyst before hitting that buy button.
Is Teladoc Stock a Buy?
Teladoc Health (TDOC 6.07%), the famed telemedicine specialist that rose to prominence in the early pandemic years, is not performing nearly as well as it once did. Over the past three years, the company's financial results have been disappointing -- at best -- and its stock price has plummeted.
Citron Research Just Called This "Pandemic Relic" Stock a Hidden Artificial Intelligence (AI) Opportunity. Time to Buy?
When analyzing stocks, listening to interviews or reading reports conducted by equity research analysts on Wall Street can be helpful. Personally, I find augmenting my own research with the findings of industry experts pretty valuable, as it helps build a more inclusive, well-rounded view of a business.
The Big 3: KC, TDOC, RDDT
From consolidation to explosive climbs, Aquiles Larrea turns to stocks that he believes are poised for more breakout opportunity. He turns to bullish indicators behind Kingsoft (KC), Teladoc Health (TDOC) and Reddit (RDDT).
Teladoc (TDOC) Surges 8.8%: Is This an Indication of Further Gains?
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Teladoc Stock Surprisingly Popped Today
Shares of telemedicine company Teladoc Health (TDOC 8.82%) surprisingly popped on Thursday after Citron Research gave it a glowing recommendation. As of 3:30 p.m.
Teladoc Pays $65 Million to Acquire Catapult Health
Virtual care company Teladoc Health is bolstering its at-home diagnostics capabilities by acquiring Catapult Health. The $65 million deal is designed to support Teladoc's efforts to improve early detection of health conditions, according to a Wednesday (Feb. 5) press release.
Teladoc Health to acquire Catapult Health in $65 million deal
Teladoc Health announced it will acquire Catapult Health in an all-cash deal for $65 million. Catapult offers an at-home wellness exam, and Teladoc said the acquisition will help it improve its ability to detect health conditions early.
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note
In the closing of the recent trading day, Teladoc (TDOC) stood at $10.05, denoting a -1.08% change from the preceding trading day.
